A review of 25 years of the social interaction test

European Journal of Pharmacology

Volumn 463, Issue 1-3, 2003, Pages 35-53

  File, Sandra E ^a   Seth, Pallab ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); Anxiety; Brain region; GABA receptor; Neuropeptide; Social interaction

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; 1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; 1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 1,3 DIHYDRO 5 METHYL 2H 1,4 BENZODIAZEPIN 2 ONE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 2 PHENYL 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 2 [[2 (DIMETHYLAMINO)ETHYL]THIO] 3 PHENYLQUINOLINE; 4' CHLORODIAZEPAM; 5 ISOPROPOXY 4 METHYL BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL] 6 TRIFLUOROMETHYLINDOLINE; 5 METHYLTHIO 1 (3 PYRIDYLCARBAMOYL) 6 (TRIFLUOROMETHYL)INDOLINE; BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; BETA CARBOLINE 3 CARBOXYLIC ACID PROPYL ESTER; BETA CARBOLINE DERIVATIVE; CHLORDIAZEPOXIDE; CORTICOTROPIN RELEASING FACTOR; DIAZEPAM; FANANSERIN; FLUMAZENIL; FLUNITRAZEPAM; GLEMANSERIN; HE 36 953; HF 200 184; LORAZEPAM; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROPEPTIDE; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NITRAZEPAM; NORDAZEPAM; OXAZEPAM; PENTETRAZOLE; PHENOBARBITAL; PICROTOXIN; SDZ 206 703; SDZ 209 321; SUBSTANCE P ANTAGONIST; TRIAZOLAM; UNINDEXED DRUG; YOHIMBINE;

ANXIETY; BRAIN REGION; DRUG WITHDRAWAL; ENVIRONMENTAL FACTOR; ETHOLOGY; GENETIC ASSOCIATION; MICROINJECTION; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; PSYCHOANALYSIS; REVIEW; SOCIAL INTERACTION;

EID: 0037470195     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01273-1     Document Type: Review

References (244)

1. Abe M., Tabata R., Saito K., Matsuda T., Baba A., Egawa M. Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models. J. Pharmacol. Exp. Ther. 278:1996;898-905.
2. 3 receptor ligands following chronic diazepam treatment? Psychopharmacology. 108:1992;333-337.
3. Andrews N., File S.E. Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence. Psychopharmacology. 112:1993;21-25.
4. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur. J. Pharmacol. 264:1994;259-264.
5. Andrews N., File S.E., Fernandes C., Gonzalez L.E., Barnes N.M. Evidence that the median raphe nucleus-dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety. Psychopharmacology. 130:1997;228-234.
6. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179:1978;641-667.
7. 1A receptor antagonist WAY-100635. Int. J. Neuropsychopharmacol. 4:2001;399-408.
8. Baldwin H.A., File S.E. Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors. Pharmacol. Biochem. Behav. 32:1989;181-186.
9. Baldwin H.A., File S.E. Flumazenil prevents the development of chlordiazepoxide withdrawal in rats tested in the social interaction test of anxiety. Psychopharmacology. 97:1989;424-426.
10. Baldwin H.A., Johnston A.L., File S.E. Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur. J. Pharmacol. 159:1989;211-215.
11. Baldwin H.A., Hitchcott P.K., File S.E. The use of flumazenil in prevention of diazepam dependence in the rat. Hum. Psychopharmacol. 5:1990;57-61.
12. 3 receptor antagonists. Pharmacol. Biochem. Behav. 37:1990;717-727.
13. Barnes N.M., Costall B., Kelly M.E., Onaivi E.S., Naylor R.J. Ketotifen and its analogues reduce aversive responding in the rodent. Pharmacol. Biochem. Behav. 37:1990;785-793.
14. Barnes N.M., Costall B., Ge J., Kelly M.E., Naylor R.J. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour. Eur. J. Pharmacol. 218:1992;15-25.
15. Becker A., Grecksch G., Bernstein H.G., Hollt V., Bogerts B. Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology. 144:1999;333-338.
16. Bellush L.L., Reid S.G., North D. The functional significance of biochemical alterations in streptozotocin-induced diabetes. Physiol. Behav. 50:1991;973-981.
17. Bhattacharya S.K. Behavioural studies on BR-16A (Mentat), a herbal psychotropic formulation. Indian J. Exp. Biol. 32:1994;37-43.
18. Bhattacharya S.K. Anxiogenic activity of centrally administered scorpion (Mesobuthus tamulus) venom in rats. Toxicon. 33:1995;1491-1499.
19. Bhattacharya S.K., Mitra S.K. Anxiogenic activity of quinine - an experimental study in rodents. Indian J. Exp. Biol. 30:1992;33-37.
20. Bhattacharya S.K., Satyan K.S., Chakrabarti A. Anxiogenic action of caffeine: an experimental study in rats. J. Psychopharmacol. 11:1997;219-224.
21. Bhattacharya S.K., Bhattacharya A., Sairam K., Ghosal S. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine. 7:2000;463-469.
22. 3 receptor antagonist with anxiolytic-like properties. Psychopharmacology. 110:1993;257-264.
23. 2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines. J. Med. Chem. 41:1998;1598-1612.
24. Cabrera R.J., Rodriguez-Echandia E.L., Jatuff A.S., Foscolo M. Effects of prenatal exposure to a mild chronic variable stress on body weight, preweaning mortality and rat behavior. Braz. J. Med. Biol. Res. 32:1999;1229-1237.
25. Cadogan A.K., Kendall D.A., Fink H., Marsden C.A. Social interaction increases 5-HT release and cAMP efflux in the rat ventral hippocampus in vivo. Behav. Pharmacol. 5:1994;299-305.
26. 2A receptor-mediated head shakes, and behaviours in models of anxiety. Neuropharmacology. 33:1994;449-456.
27. Cheeta S., Kenny P.J., File S.E. Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatry. 24:2000;1053-1067.
28. 1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration. Eur. J. Neurosci. 12:2000;3797-3802.
29. Cheeta S., Irvine E., File S.E. Social isolation modifies nicotine's effects in animal tests of anxiety. Br. J. Pharmacol. 132:2001;1389-1395.
30. Cheeta S., Irvine E.E., Kenny P.J., File S.E. The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology. 155:2001;78-85.
31. Cheeta S., Irvine E.E., Tucci S., Sandhu J., File S.E. In adolescence, female rats are more sensitive to the anxiolytic effect of nicotine than are male rats. Neuropsychopharmacology. 25:2001;601-607.
32. Cheeta S., Tucci S., File S.E. Antagonism of the anxiolytic effect of nicotine in the dorsal raphe nucleus by dihydro-β-erythroidine. Pharmacol. Biochem. Behav. 70:2001;491-496.
33. 1A agonist 8-OH-DPAT in the social interaction test in gerbils. Brain Res. 915:2001;170-175.
34. Chermat R., Brochet D., DeFeudis F.V., Drieu K. Interactions of Ginkgo biloba extract (EGb 761), diazepam and ethyl beta-carboline-3-carboxylate on social behavior of the rat. Pharmacol. Biochem. Behav. 56:1997;333-339.
35. Clarke A., File S.E. Infundibular ACTH can be excluded as a critical mediator in social behaviours. Brain Res. Bull. 6:1981;39-46.
36. Clarke A., File S.E. Selective neurotoxin lesions of the lateral septum: changes in social and aggressive behaviours. Pharmacol. Biochem. Behav. 17:1982;623-628.
37. Clarke A., File S.E. Social and exploratory behaviour in the rat after septal administration of ORG 2766 and ACTH4-10. Psychoneuroendocrinology. 8:1983;343-350.
38. 3 receptor antagonists. Pharmacol. Toxicol. 70:1992;157-162.
39. Costall B., Naylor R.J. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations. Br. J. Pharmacol. 116:1995;2989-2999.
40. Costall B., Domeney A.M., Gerrard P.A., Kelly M.E., Naylor R.J. Zacopride: anxiolytic profile in rodent and primate models of anxiety. J. Pharm. Pharmacol. 40:1988;302-305.
41. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Oakley N.R., Onaivi E.S., Tyers M.B. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol. Biochem. Behav. 34:1989;769-778.
42. Costall B., Domeney A.M., Gerrard P.A., Horovitz Z.P., Kelly M.E., Naylor R.J., Tomkins D.M. Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset. Pharmacol. Biochem. Behav. 36:1990;13-20.
43. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Onaivi E.S., Tyers M.B. Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacol. Biochem. Behav. 36:1990;339-344.
44. Costall B., Kelly M.E., Onaivi E.S., Naylor R.J. The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse. Naunyn Schmiedeberg's Arch. Pharmacol. 341:1990;547-551.
45. Costall B., Domeney A.M., Hughes J., Kelly M.E., Naylor R.J., Woodruff G.N. Anxiolytic effects of CCK-B antagonists. Neuropeptides. 19:1991;65-73. (Suppl.).
46. Costall B., Domeney A.M., Farre A.J., Kelly M.E., Martinez L., Naylor R.J. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset. J. Pharmacol. Exp. Ther. 262:1992;90-98.
47. 3 receptor antagonist, RS-42358-197, in animal models of anxiety. Eur. J. Pharmacol. 234:1993;91-99.
48. Crow T.J., Deakin J.F., File S.E., Longden A., Wendlandt S. The locus coeruleus noradrenergic system - evidence against a role in attention, habituation, anxiety and motor activity. Brain Res. 155:1978;249-261.
49. 3 receptor antagonists, BRL 43694 and ICS 205-930, under circumstances of high and low light intensity. Neuropharmacology. 29:1990;515-520.
50. Cutler M.G. Potential anxiolytic activity in gerbils from the substance P (SP) receptor antagonist, CGP 49823. J. Psychopharmacol. A22:1994.
51. 3 receptor antagonist BRL 43694; effects on reflex epilepsy and social behaviour of the Mongolian gerbil. Psychopharmacology. 101:1990;244-249.
52. Cutler M.G., Rodgers R.J., Jackson J.E. Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine: I. Social interactions. Pharmacol. Biochem. Behav. 56:1997;287-293.
53. Deacon R.M., Bannerman D.M., Rawlins J.N. Anxiolytic effects of cytotoxic hippocampal lesions in rats. Behav. Neurosci. 116:2002;494-497.
54. de Angelis L., File S.E. Acute and chronic effects of three benzodiazepines in the social interaction anxiety test in mice. Psychopharmacology. 64:1979;127-129.
55. de Bruin J.P., van Oyen H.G., Van de Poll N. Behavioural changes following lesions of the orbital prefrontal cortex in male rats. Behav. Brain Res. 10:1983;209-232.
56. 1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents. Psychopharmacology. 152:2000;55-66.
57. 2C receptors. Neuropharmacology. 39:2000;1114-1117.
58. Dunn A.J., File S.E. Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm. Behav. 21:1987;193-202.
59. 1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur. J. Pharmacol. 169:1989;1-10.
60. 3 antagonists ondansetron, zacopride, 3a-tropanyl-1H-indole-3-carboxylic acid ester, and 1aH, 3a, 5aH-tropan-3-yl-3,5-dichlorobenzoate. Drug Dev. Res. 23:1991;289-300.
61. 2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat. Neuropharmacology. 36:1997;601-608.
62. 1A receptor antagonist WAY100635. Br. J. Pharmacol. 130:2000;1713-1791.
63. Edwards D.A., Nahai F.R., Wright P. Pathways linking the olfactory bulbs with the medial preoptic anterior hypothalamus are important for intermale aggression in mice. Physiol. Behav. 53:1993;611-615.
64. 3 receptor antagonism. Pharmacol. Biochem. Behav. 68:2001;677-683.
65. Elkabir D.R., Wyatt M.E., Vellucci S.V., Herbert J. The effects of separate or combined infusions of corticotropin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat. Regul. Pept. 28:1990;199-214.
66. Fernandes C., Arnot M.I., Irvine E.E., Bateson A.N., Martin I.L., File S.E. The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam. Psychopharmacology. 145:1999;251-259.
67. File S.E. Effects of ACTH4-10 in the social interaction test of anxiety. Brain Res. 171:1979;157-160.
68. File S.E. ACTH as a mediator in anxiety. Saletu B., Berner P., Hollister L. Neuropsychopharmacology. 1979;439-448 Pergamon, Oxford.
69. File S.E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods. 2:1980;219-238.
70. File S.E. Naloxone reduces social and exploratory activity in the rat. Psychopharmacology. 71:1980;41-44.
71. File S.E. Contrasting effects of Org 2766 and α-MSH on social and exploratory behavior in the rat. Peptides. 2:1981;255-260.
72. File S.E. Animal anxiety and the effects of benzodiazepines. Usdin E., Skolnick P., Tallman J., Greenblatt D., Paul S. Pharmacology of the Benzodiazepines. 1982;355-364 Macmillan, London.
73. File S.E. The validation of animal tests of anxiety - pharmacological implications. Pol. J. Pharmacol. Pharm. 36:1984;505-512.
74. File S.E. Effects of neonatal administration of diazepam and lorazepam on performance of adolescent rats in tests of anxiety, aggression, learning and convulsions. Neurobehav. Toxicol. Teratol. 8:1986;301-306.
75. File S.E. Behavioral changes persisting into adulthood after neonatal benzodiazepine administration in the rat. Neurobehav. Toxicol. Teratol. 8:1986;453-461.
76. File S.E. Anxiolytic and anxiogenic drugs: changes in behaviour and endocrine responses. Stress Med. 4:1988;221-230.
77. File S.E. Chronic exposure to noise modifies the anxiogenic response, but not the hypoactivity, detected on withdrawal from chronic ethanol treatment. Psychopharmacology. 116:1994;369-372.
78. File S.E. Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test. Pharmacol. Biochem. Behav. 58:1997;747-752.
79. 1 receptor antagonist, has an anxiolytic action in the social interaction test in rats. Psychopharmacology. 152:2000;105-109.
80. File S.E., Andrews N. Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal. Psychopharmacology. 105:1991;578-582.
81. File S.E., Andrews N. Benzodiazepine withdrawal: behavioural pharmacology and neurochemical changes. Biochem. Soc. Symp. 59:1993;97-106.
82. 1A agonists in drug-naive and in benzodiazepine-experienced rats. Behav. Pharmacol. 5:1994;99-102.
83. File S.E., Clarke A. Intraventricular ACTH reduces social interaction in male rats. Pharmacol. Biochem. Behav. 12:1980;711-715.
84. File S.E., Deakin J.F. Chemical lesions of both dorsal and median raphe nuclei and changes in social and aggressive behaviour in rats. Pharmacol. Biochem. Behav. 12:1980;855-859.
85. File S.E., Guardiola-Lemaitre B.J. L-fenfluramine in tests of dominance and anxiety in the rat. Neuropsychobiology. 20:1988;205-211.
86. File S.E., Hitchcott P.K. A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena. Psychopharmacology. 101:1990;525-532.
87. File S.E., Hyde J.R. Can social interaction be used to measure anxiety? Br. J. Pharmacol. 62:1978;19-24.
88. File S.E., Hyde J.R. A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. Pharmacol. Biochem. Behav. 11:1979;65-69.
89. 3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology. 99:1989;248-251.
90. File S.E., Lister R.G. Interactions of ethyl-β-carboline-3-carboxylate and Ro 15-1788 with CGS 8216 in an animal model of anxiety. Neurosci. Lett. 39:1983;91-94.
91. File S.E., Lister R.G. The anxiogenic action of Ro 5-4864 is reversed by phenytoin. Neurosci. Lett. 35:1983;93-96.
92. File S.E., Lister R.G. Do the reductions in social interaction produced by picrotoxin and pentylenetetrazole indicate anxiogenic actions? Neuropharmacology. 23:1984;793-796.
93. File S.E., Peet L.A. The sensitivity of the rat corticosterone response to environmental manipulations and to chronic chlordiazepoxide treatment. Physiol. Behav. 25:1980;753-758.
94. File S.E., Pellow S. Anxiogenic action of a convulsant benzodiazepine: reversal by chlordiazepoxide. Brain Res. 278:1983;370-372.
95. File S.E., Pellow S. The anxiogenic action of Ro 15-1788 is reversed by chronic, but not by acute, treatment with chlordiazepoxide. Brain Res. 310:1984;154-156.
96. File S.E., Pellow S. Does the benzodiazepine antagonist Ro 15-1788 reverse the actions of picrotoxin and pentylenetetrazole on social and exploratory behaviour? Arch. Int. Pharmacodyn. Ther. 277:1985;272-279.
97. File S.E., Pellow S. The effects of PK 11195, a ligand for benzodiazepine binding sites, in animal tests of anxiety and stress. Pharmacol. Biochem. Behav. 23:1985;737-741.
98. File S.E., Pellow S. The anxiogenic action of Ro 5-4864 in the social interaction test: effect of chlordiazepoxide, Ro 15-1788 and CGS 8216. Naunyn Schmiedeberg's Arch. Pharmacol. 328:1985;225-228.
99. File S.E., Pellow S. Triazolobenzodiazepines antagonize the effects of anxiogenic drugs mediated at three different central nervous system sites. Neurosci. Lett. 61:1985;115-119.
100. File S.E., Rodgers R.J. Partial anxiolytic action of morphine sulphate following microinjection into the central nucleus of the amygdala in rats. Pharmacol. Biochem. Behav. 11:1979;313-318.
101. File S.E., Tucker J.C. Neonatal clomipramine treatment in the rat does not affect social, sexual and exploratory behaviors in adulthood. Neurobehav. Toxicol. Teratol. 5:1983;3-8.
102. File S.E., Tucker J.C. Lorazepam treatment in the neonatal rat alters submissive behavior in adulthood. Neurobehav. Toxicol. Teratol. 5:1983;289-294.
103. File S.E., Tucker J.C. Prenatal treatment with clomipramine: effects on the behaviour of male and female adolescent rats. Psychopharmacology. 82:1984;221-224.
104. File S.E., Tucker J.C. Chronic neonatal treatment with CGS 8216: effects on the behaviour of adolescent rats. Behav. Brain Res. 11:1984;197-204.
105. File S.E., Tucker J.C. Lasting behavioral effects after treating rats with CGS 8216 on postnatal days 9 to 21. Physiol. Behav. 32:1984;351-355.
106. File S.E., Vellucci S.V. Studies on the role of ACTH and of 5-HT in anxiety, using an animal model. J. Pharm. Pharmacol. 30:1978;105-110.
107. File S.E., Vellucci S.V. Behavioural and biochemical measures of stress in hooded rats from different sources. Physiol. Behav. 22:1979;31-35.
108. File S.E., Hyde J., Pool M. Effects of ethanol and chlordiazepoxide on social interaction in rats. Br. J. Pharmacol. 58:1976;. (465 pp.).
109. File S.E., Deakin J.F., Longden A., Crow T.J. An investigation of the role of the locus coeruleus in anxiety and agonistic behaviour. Brain Res. 169:1979;411-420.
110. File S.E., Hyde J.R., MacLeod N.K. 5,7-dihydroxytryptamine lesions of dorsal and median raphe nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. J. Affect. Disord. 1:1979;115-122.
111. File S.E., Vellucci S.V., Wendlandt S. Corticosterone - an anxiogenic or an anxiolytic agent? J. Pharm. Pharmacol. 31:1979;300-305.
112. File S.E., James T.A., MacLeod N.K. Depletion in amygdaloid 5-hydroxytryptamine concentration and changes in social and aggressive behaviour. J. Neural Transm. 50:1981;1-12.
113. File S.E., Lister R.G., Nutt D.J. The anxiogenic action of benzodiazepine antagonists. Neuropharmacology. 21:1982;1033-1037.
114. File S.E., Lister R.G., Maninov R., Tucker J.C. Intrinsic behavioural actions of n-propyl β-carboline-3-carboxylate. Neuropharmacology. 23:1984;463-466.
115. File S.E., Pellow S., Braestrup C. Effects of the β-carboline, FG 7142, in the social interaction test of anxiety and the holeboard: correlations between behaviour and plasma concentrations. Pharmacol. Biochem. Behav. 22:1985;941-944.
116. File S.E., Pellow S., Jensen L.H. Actions of the beta-carboline ZK 93426 in an animal test of anxiety and the holeboard: interactions with Ro 15-1788. J. Neural Transm. 65:1986;103-114.
117. File S.E., Baldwin H.A., Johnston A.L., Wilks L.J. Behavioral effects of acute and chronic administration of caffeine in the rat. Pharmacol. Biochem. Behav. 30:1988;809-815.
118. File S.E., Baldwin H.A., Hitchcott P.K. Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat. Psychopharmacology. 98:1989;262-264.
119. File S.E., Mabbutt P.S., Andrews N. Diazepam withdrawal responses measured in the social interaction test of anxiety and their reversal by baclofen. Psychopharmacology. 104:1991;62-66.
120. File S.E., Zharkovsky A., Gulati K. Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat. Neuropharmacology. 30:1991;183-190.
121. File S.E., Zharkovsky A., Hitchcott P.K. Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal. Prog. Neuropsychopharmacol. Biol. Psychiatry. 16:1992;87-93.
122. File S.E., Andrews N., al-Farhan M. Anxiogenic responses of rats on withdrawal from chronic ethanol treatment: effects of tianeptine. Alcohol Alcohol. 28:1993;281-286.
123. File S.E., Andrews N., Zangrossi H. Jr. Tianeptine counteracts the anxiogenic effects of benzodiazepine withdrawal, but not those of exposure to cat odour. Eur. Psychiatry. 8:1993;75s-80s.
124. File S.E., Zangrossi H. Jr., Andrews N. Social interaction and elevated plus-maze tests: changes in release and uptake of 5-HT and GABA. Neuropharmacology. 32:1993;217-221.
125. 1A receptor modulation of anxiety in two ethological animal tests. J. Neurosci. 16:1996;4810-4815.
126. File S.E., Kenny P.J., Ouagazzal A.M. Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav. Neurosci. 112:1998;1423-1429.
127. 1A receptor function. Pharmacol. Biochem. Behav. 62:1999;695-701.
128. File S.E., Kenny P.J., Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav. 66:2000;65-72.
129. File S.E., Cheeta S., Akanezi C. Diazepam and nicotine increase social interaction in gerbils: a test for anxiolytic action. Brain Res. 888:2001;311-313.
130. Gardner C.R., Guy A.P. A social interaction model of anxiety sensitive to acutely administered benzodiazepines. Drug Dev. Res. 4:1984;207-216.
131. 1 dopamine receptors in high- and low-aggressive mice. Pharmacol. Biochem. Behav. 51:1995;767-773.
132. 1 dopamine receptors and the reversal of isolation-induced behaviors in mice. Behav. Brain Res. 95:1998;103-111.
133. Ge J., Barnes N.M., Costall B., Naylor R.J. Effect of aversive stimulation on 5-hydroxytryptamine and dopamine metabolism in the rat brain. Pharmacol. Biochem. Behav. 58:1997;775-783.
134. Genn R.F., Tucci S., Thomas A., Edwards J.E., File S.E. Sex differences in response to food deprivation on two animal tests of anxiety. Neurosci. Biobehav. Rev. 2002;. (submitted for publication).
135. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res. 732:1996;145-153.
136. 1A receptor function: a link between anxiety and depression? Pharmacol. Biochem. Behav. 59:1998;787-792.
137. Gonzalez L.E., Ouagazzal A.M., File S.E. Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphe reveals differential GABAergic control in two animal tests of anxiety. Eur. J. Neurosci. 10:1998;3673-3680.
138. Gonzalez L.E., Rujano M., Tucci S., Paredes D., Silva E., Alba G., Hernandez L. Medial prefrontal transection enhances social interaction: I. Behavioral studies. Brain Res. 887:2000;7-15.
139. Guy A.P., Gardner C.R. Pharmacological characterisation of a modified social interaction model of anxiety in the rat. Neuropsychobiology. 13:1985;194-200.
140. Haller J., Halasz J., Makara G.B. Housing conditions and the anxiolytic efficacy of buspirone: the relationship between main and side effects. Behav. Pharmacol. 11:2000;403-412.
141. Harro J., Tonissaar M., Eller M. The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat. Neuropeptides. 35:2001;100-109.
142. Hartley D.E., Edwards J.E., Spiller C.E., Alom N., Tucci S., Seth P., Forsling M.L., File S.E. The soya isoflavone content of rat diet can increase anxiety and stress hormone release and anxiety in the male rat. Psychopharmacology. 2002;. (in press).
143. Hasenohrl R.U., Jentjens O., De Souza Silva M.A., Tomaz C., Huston J.P. Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region. Eur. J. Pharmacol. 354:1998;123-133.
144. 1-like and GABA receptors in the dorsal raphe nucleus of the rat. Neuropharmacology. 27:1988;993-1001.
145. 3 receptor antagonists. Psychopharmacology. 104:1991;545-551.
146. 1A receptor agonists in two models of anxiety after dorsal raphe injection. Psychopharmacology. 106:1992;261-267.
147. Hilakivi L.A., Durcan M.J., Lister R.G. Effects of caffeine on social behavior, exploration and locomotor activity: interactions with ethanol. Life Sci. 44:1989;543-553.
148. Hilakivi-Clarke L.A., Wozniak K.M., Durcan M.J., Linnoila M. Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiol. Behav. 48:1990;429-433.
149. Hindley S.W., Hobbs A., Paterson I.A., Roberts M.H. The effects of methyl beta-carboline-3-carboxylate on social interaction and locomotor activity when microinjected into the nucleus raphe dorsalis of the rat. Br. J. Pharmacol. 86:1985;753-761.
150. Hogg S., Andrews N., File S.E. Contrasting behavioural effects of 8-OH-DPAT in the dorsal raphe nucleus and ventral hippocampus. Neuropharmacology. 33:1994;343-348.
151. Holson R.R., Walker C. Mesial prefrontal cortical lesions and timidity in rats: II. Reactivity to novel stimuli. Physiol. Behav. 37:1986;231-238.
152. Irvine E.E., Cheeta S., File S.E. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav. Pharmacol. 10:1999;691-697.
153. Irvine E.E., Cheeta S., File S.E. Development of tolerance to nicotine's anxiogenic effect in the social interaction test. Brain Res. 894:2001;95-100.
154. Irvine E.E., Cheeta S., Lovelock C., File S.E. Tolerance to midazolam's anxiolytic effects after short-term nicotine treatment. Neuropharmacology. 40:2001;710-716.
155. Irvine E.E., Cheeta S., Marshall M., File S.E. Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects. Pharmacol. Biochem. Behav. 68:2001;769-776.
156. 3 antagonists in two animal tests of anxiety. Neurosci. Lett. 32:1988;S44. (Suppl.).
157. Johnston A.L., File S.E. Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety. Psychiatry Res. 25:1988;81-90.
158. Johnston A.L., File S.E. Sodium phenobarbitone reverses the anxiogenic effects of compounds acting at three different central sites. Neuropharmacology. 28:1989;83-88.
159. Johnston A.L., File S.E. Sex differences in animal tests of anxiety. Physiol. Behav. 49:1991;245-250.
160. 3-receptor antagonist. Br. J. Pharmacol. 93:1988;985-993.
161. Kampov-Polevoy A.B., Matthews D.B., Gause L., Morrow A.L., Overstreet D.H. P rats develop physical dependence on alcohol via voluntary drinking: changes in seizure thresholds, anxiety, and patterns of alcohol drinking. Alcohol., Clin. Exp. Res. 24:2000;278-284.
162. Kantor S., Anheuer Z.E., Bagdy G. High social anxiety and low aggression in Fawn-hooded rats. Physiol. Behav. 71:2000;551-557.
163. 1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test. NeuroReport. 9:1998;2713-2716.
164. Kask A., Nguyen H.P., Pabst R., von Horsten S. Factors influencing behavior of group-housed male rats in the social interaction test: focus on cohort removal. Physiol. Behav. 74:2001;277-282.
165. 1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety. Neuroscience. 104:2001;799-806.
166. Kellogg C.K., Primus R.J., Bitran D. Sexually dimorphic influence of prenatal exposure to diazepam on behavioral responses to environmental challenge and on gamma-aminobutyric acid (GABA)-stimulated chloride uptake in the brain. J. Pharmacol. Exp. Ther. 256:1991;259-265.
167. A receptor in the cerebral cortex: a non-corticosterone influence. Brain Res. 609:1993;244-252.
168. Kennedy A.J., Gibson E.L., O'Connell M.T., Curzon G. Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP. Psychopharmacology. 113:1993;262-268.
169. 1C receptor antagonists. Eur. J. Pharmacol. 164:1989;445-454.
170. 2C/2B receptor antagonist. Br. J. Pharmacol. 111:1994;797-802.
171. 2B receptor agonist, BW 723C86, on three rat models of anxiety. Br. J. Pharmacol. 117:1996;1443-1448.
172. 2B receptor antagonist with anxiolytic-like properties. Br. J. Pharmacol. 117:1996;427-434.
173. 2C receptor antagonist. Neuropharmacology. 36:1997;609-620.
174. 2C receptor agonist, in three animal models of anxiety. Eur. J. Pharmacol. 387:2000;197-204.
175. 1 receptors. Neuropharmacology. 39:2000;300-307.
176. Knapp D.J., Overstreet D.H., Breese G.R. Involvement of 5-HT2C receptors in anxiety induced by repeated alcohol withdrawals. Soc. Neurosci. Abstr. 27. 2001;. Program No. 980.13.
177. Koenig M., Zimmer A.M., Steiner H., Holmes P.V., Crawley J.N., Brownstein M.J., Zimmer A. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature. 383:1996;535-538.
178. Krsiak M., Sulcova A. Differential effects of six structurally related benzodiazepines on some ethological measures of timidity, aggression and locomotion in mice. Psychopharmacology. 101:1990;396-402.
179. Krsiak M., Sulcova A., Donat P., Tomasikova Z., Dlohozkova N., Kosar E., Masek K. Can social and agonistic interactions be used to detect anxiolytic activity of drugs? Prog. Clin. Biol. Res. 167:1984;93-114.
180. 2A receptor, and 5-HT transporter binding in grouped and isolated Roman RHA and RLA rats: relationships with behaviours in two models of anxiety. Psychopharmacology. 121:1995;385-395.
181. Kumar V., Jaiswal A.K., Singh P.N., Bhattacharya S.K. Anxiolytic activity of Indian Hypericum perforatum Linn: an experimental study. Indian J. Exp. Biol. 38:2000;36-41.
182. Lapin I.P. β-phenylethylamine (PEA): an endogenous anxiogen? Three series of experimental data. Biol. Psychiatry. 28:1990;997-1003.
183. 1 dopamine receptors: studies in mice selectively bred for high and low levels of aggression. Neuropsychopharmacology. 10:1994;115-122.
184. Lightowler S., Kennett G.A., Williamson I.J., Blackburn T.P., Tulloch I.F. Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol. Biochem. Behav. 49:1994;281-285.
185. Lister R.G., Hilakivi L.A. The effects of novelty, isolation, light and ethanol on the social behavior of mice. Psychopharmacology. 96:1988;181-187.
186. Maciag C.M., Dent G., Gilligan P., He L., Dowling K., Ko T., Levine S., Smith M.A. Effects of a non-peptide CRF antagonist (DMP696) on the behavioral and endocrine sequelae of maternal separation. Neuropsychopharmacology. 26:2002;574-582.
187. Moreira E.C., Nascimento N., Rosa G.J., Rogero J.R., Vassilieff V.S. Effect of gamma irradiation on the behavioral properties of crotoxin. Braz. J. Med. Biol. Res. 30:1997;245-249.
188. Moreira E.G., Nascimento N., Rogero J.R., Vassilieff V.S. GABAergic-benzodiazepine system is involved in the crotoxin-induced anxiogenic effect. Pharmacol. Biochem. Behav. 65:2000;7-13.
189. Millan M.J., Brocco M., Gobert A., Dorey G., Casara P., Dekeyne A. Anxiolytic properties of the selective, non-peptidergic CRF1 antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent. Neuropsychopharmacology. 25:2001;585-600.
190. Niesink R.J., van Ree J.M. Short-term isolation increases social interactions of male rats: a parametric analysis. Physiol. Behav. 29:1982;819-825.
191. Olivier B., Mos J. Serotonin, serenics and aggressive behaviour in animals. Swinkels J.A., Blijleven W. Depression, Anxiety and Aggression. Factors that Influence the Course. 1988;133-165 Medidact, Houten.
192. Olivier B., Mos J., van der Heyden J., Hartog J. Serotonergic modulation of social interactions in isolated male mice. Psychopharmacology. 97:1989;154-156.
193. 3 receptor antagonists and anxiety; a preclinical and clinical review. Eur. Neuropsychopharmacol. 10:2000;77-95.
194. Ouagazzal A.M., Kenny P.J., File S.E. Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. Eur. J. Neurosci. 11:1999;3957-3962.
195. Overstreet D.H., Knapp D.J., Breese G.R. Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol., Clin. Exp. Res. 26:2002;1259-1268.
196. Pellow S., File S.E. Can anti-panic drugs antagonise the anxiety produced in the rat by drugs acting at the GABA-benzodiazepine receptor complex? Neuropsychobiology. 17:1987;60-65.
197. Pellow S., Chopin P., File S.E. Are the anxiogenic effects of yohimbine mediated by its action at benzodiazepine receptors? Neurosci. Lett. 55:1985;5-9.
198. 1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action. Brain Res. Bull. 37:1995;169-175.
199. 3 receptor antagonists BRL-43694 and GR 38032F in animal behavioural models of anxiety. Br. J. Pharmacol. 94:1988;. (314 pp.).
200. Primus R.J., Kellogg C.K. Gonadal hormones during puberty organize environment-related social interaction in the male rat. Horm. Behav. 24:1990;311-323.
201. Primus R.J., Kellogg C.K. Developmental influence of gonadal function on the anxiolytic effect of diazepam on environment-related social interaction in the male rat. Behav. Pharmacol. 1:1990;437-446.
202. Ramanathan M., Jaiswal A.K., Bhattacharya S.K. Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats. Psychopharmacology. 135:1998;361-367.
203. Ramanathan M., Jaiswal A.K., Bhattacharya S.K. Hyperglycaemia in pregnancy: effects on the offspring behaviour with special reference to anxiety paradigms. Indian J. Exp. Biol. 38:2000;231-236.
204. 3 antagonist U-99194A maleate increases social behaviors of isolation-induced aggressive male mice. Psychopharmacology. 144:1999;90-94.
205. 3 antagonist, in benzodiazepine discontinuation. J. Clin. Psychopharmacol. 18:1998;121-131.
206. Sajdyk T.J., Gehlert D.R. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala. Brain Res. 877:2000;226-234.
207. A receptor blockade in the basolateral amygdala of rats. J. Pharmacol. Exp. Ther. 283:1997;969-977.
208. Sajdyk T.J., Shekhar A. Excitatory amino acid receptors in the basolateral amygdala regulate anxiety responses in the social interaction test. Brain Res. 764:1997;262-264.
209. Sajdyk T.J., Shekhar A. Sodium lactate elicits anxiety in rats after repeated GABA receptor blockade in the basolateral amygdala. Eur. J. Pharmacol. 394:2000;265-273.
210. Sajdyk T.J., Katner J.S., Shekhar A. Monoamines in the dorsomedial hypothalamus of rats following exposure to different tests of "anxiety" Prog. Neuropsychopharmacol. Biol. Psychiatry. 21:1997;193-209.
211. Sajdyk T.J., Schober D.A., Gehlert D.R., Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav. Brain Res. 100:1999;207-215.
212. 1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur. J. Pharmacol. 368:1999;143-147.
213. 2 receptors mediate anxiety in the amygdala. Pharmacol. Biochem. Behav. 71:2002;419-423.
214. Saldivar-Gonzalez A., Gomez C., Martinez-Lomeli I., Arias C. Effect of flumazenil and diazepam on transient actions in defensive burying elicited by the social interaction experience in rats. Pharmacol. Biochem. Behav. 66:2000;265-273.
215. Sams-Dodd F. Distinct effects of D-amphetamine and phencyclidine on the social behaviour of rats. Behav. Pharmacol. 6:1995;55-65.
216. Sams-Dodd F. Effect of novel antipsychotic drugs on phencyclidine-induced stereotyped behaviour and social isolation in the rat social interaction test. Behav. Pharmacol. 8:1997;196-215.
217. Sams-Dodd F. Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats. Neuropsychopharmacology. 19:1998;18-25.
218. Sams-Dodd F. Effects of diazepam, citalopram, methadone and naloxone on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test. Neurosci. Biobehav. Rev. 23:1998;287-293.
219. Sams-Dodd F. Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Rev. Neurosci. 10:1999;59-90.
220. Sams-Dodd F., Lipska B.K., Weinberger D.R. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology. 132:1997;303-310.
221. A and benzodiazepine receptor antagonists in the region of the anterior basolateral amygdala of rats. Biol. Psychiatry. 37:1995;473-476.
222. A receptors in the rat amygdala. Pharmacol. Biochem. Behav. 52:1995;701-706.
223. 1B receptor. Science. 265:1994;1875-1878.
224. Satyan K.S., Jaiswal A.K., Ghosal S., Bhattacharya S.K. Anxiolytic activity of ginkgolic acid conjugates from Indian Ginkgo biloba. Psychopharmacology. 136:1998;148-152.
225. 3 Antagonists and Benodiazepines: Their Comparative Behavioural Pharmacology. 1991;365-376 Wiley, Chichester.
226. Shekhar A., Katner J.S. Dorsomedial hypothalamic GABA regulates anxiety in the social interaction test. Pharmacol. Biochem. Behav. 50:1995;253-258.
227. Szewczak M.R., Corbett R., Rush D.K., Wilmot C.A., Conway P.G., Strupczewski J.T., Cornfeldt M. The pharmacological profile of iloperidone, a novel atypical antipsychotic agent. J. Pharmacol. Exp. Ther. 274:1995;1404-1413.
228. Taylor S.C., Johnston A.L., Wilks L.J., Nicholass J.M., File S.E., Little H.J. Kindling with the beta-carboline FG7142 suggests separation between changes in seizure threshold and anxiety-related behaviour. Neuropsychobiology. 19:1988;195-201.
229. Taylor G., Farr S., Griffin M., Humphrey W., Weiss J. Adult ontogeny of rat working memory of social interactions. J. Gerontol., Ser. A., Biol. Sci. Med. Sci. 54:1999;M145-M151.
230. Thorre K., Chaouloff F., Sarre S., Meeusen R., Ebinger G., Michotte Y. Differential effects of restraint stress on hippocampal 5-HT metabolism and extracellular levels of 5-HT in streptozotocin-diabetic rats. Brain Res. 772:1997;209-216.
231. To C.T., Bagdy G. Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment. Neuropharmacology. 38:1999;279-282.
232. To C.T., Anheuer Z.E., Bagdy G. Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety. NeuroReport. 10:1999;553-555.
233. 3 antagonists in laboratory animals. Neurosci. Lett. 29:1987;S68.
234. Vale A.L., Montgomery A.M. Social interaction: responses to chlordiazepoxide and the loss of isolation-reared effects with paired-housing. Psychopharmacology. 133:1997;127-132.
235. Varlinskaya E.I., Spear L.P., Spear N.E. Acute effects of ethanol on behavior of adolescent rats: role of social context. Alcohol., Clin. Exp. Res. 25:2001;377-385.
236. Vassout A., Veenstra S., Hauser K., Ofner S., Brugger F., Schilling W., Gentsch C. NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats. Regul. Pept. 96:2000;7-16.
237. Vellucci S.V., File S.E. Chlordiazepoxide loses its anxiolytic action with long-term treatment. Psychopharmacology. 62:1979;61-65.
238. Whitton P., Curzon G. Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus. Psychopharmacology. 100:1990;138-140.
239. Wilde M.I., Markham A. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications. Drugs. 52:1996;773-794.
240. Wongwitdecha N., Marsden C.A. Social isolation increases aggressive behaviour and alters the effects of diazepam in the rat social interaction test. Behav. Brain Res. 75:1996;27-32.
241. 2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. Neuropharmacology. 41:2001;186-199.
242. Yamada K., Wada E., Wada K. Male mice lacking the gastrin-releasing peptide receptor (GRP-R) display elevated preference for conspecific odors and increased social investigatory behaviors. Brain Res. 870:2000;20-26.
243. Zangrossi H.Jr., File S.E. Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res. Bull. 29:1992;381-388.
244. Zangrossi H. Jr., File S.E. Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor. Pharmacol. Biochem. Behav. 43:1992;195-200.